Sacubitril/valsartan reverses cardiac structure and function in experimental model of hypertension-induced hypertrophic cardiomyopathy-Reference-Cited by-同舟云学术

Sacubitril/valsartan reverses cardiac structure and function in experimental model of hypertension-induced hypertrophic cardiomyopathy

Published:2023-03-30 Issue:12 Volume:478 Page:2645-2656
ISSN:0300-8177
Container-title:Molecular and Cellular Biochemistry
language:en
Short-container-title:Mol Cell Biochem

Author:

Jeremic Jovana,Govoruskina Natalia,Bradic Jovana,Milosavljevic Isidora,Srejovic Ivan,Zivkovic Vladimir,Jeremic Nevena,Nikolic Turnic Tamara,Tanaskovic Irena,Bolevich Stefani,Jakovljevic Vladimir,Bolevich Sergey,Zivanovic Marko N.,Okwose Nduka,Seklic Dragana,Milivojevic Nevena,Grujic Jelena,Velicki Lazar,MacGowan Guy,Jakovljevic Djordje G.,Filipovic Nenad

Funder

European Union’s Horizon 2020 research and innovation programme

Ministry of Education, Science and Technological Development of the Republic of Serbia

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11010-023-04690-7.pdf

Reference39 articles.

1. Bijani M, Parvizi S, Dehghan A, Sedigh-Rahimabadi M, Rostami-chijan M, Kazemi M et al (2020) Investigating the prevalence of hypertension and its associated risk factors in a population-based study: Fasa PERSIAN COHORT data. BMC Cardiovasc Disord. https://doi.org/10.1186/s12872-020-01797-3

2. Mills KT, Stefanescu A, He J (2020) The global epidemiology of hypertension. Nat Rev Nephrol 16:223–237. https://doi.org/10.1038/s41581-019-0244-2